Akari Therapeutics Plc (AKTX) Form 10-K Annual Reports
Akari Therapeutics Plc (AKTX) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: AKTX
CIK: 1541157
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 12/31
State: X0
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
BDO USA, P.C.
Auditor SinceSince 12/31/2023 12:00:00 AM
Lead Engagement PartnerJoseph Scheriff
Audit LocationNew York, New York, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 4 | 2026-10-16 | 2026-08-18 | 4 | 0001493152-26-047458 | View SEC Doc Filr Page |
| 4 | 2026-10-16 | 2026-08-18 | 4 | 0001493152-26-047457 | View SEC Doc Filr Page |
| 4 | 2026-10-16 | 2026-08-18 | 4 | 0001493152-26-047456 | View SEC Doc Filr Page |
| 4 | 2026-10-16 | 2026-08-18 | 4 | 0001493152-26-047455 | View SEC Doc Filr Page |
| 4 | 2026-10-16 | 2026-08-18 | 4 | 0001493152-26-047454 | View SEC Doc Filr Page |
| 4 | 2026-10-16 | 2026-08-18 | 4 | 0001493152-26-047453 | View SEC Doc Filr Page |
| 4 | 2026-10-14 | 2026-10-12 | 4 | 0001493152-26-047058 | View SEC Doc Filr Page |
| 3 | 2026-10-14 | 2026-10-12 | 3 | 0001493152-26-047057 | View SEC Doc Filr Page |
| DEF 14A | 2026-10-01 | 2026-10-01 | DEF 14A | 0001493152-26-045371 | View SEC Doc Filr Page |
| 4 | 2026-10-01 | 2026-09-29 | 4 | 0001493152-26-045366 | View SEC Doc Filr Page |
| 8-K | 2026-10-01 | 2026-09-29 | 8-K | 0001493152-26-045364 | View SEC Doc Filr Page |
| 4 | 2026-08-19 | 2026-08-17 | 4 | 0001493152-26-039246 | View SEC Doc Filr Page |
| 8-K | 2026-08-13 | 2026-08-13 | 8-K | 0001493152-26-037736 | View SEC Doc Filr Page |
| 10-Q | 2026-08-13 | 2026-06-30 | 10-Q | 0001493152-26-037730 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-12 | — | SCHEDULE 13G Filing | 0000927971-26-000091 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-08-07 | — | SCHEDULE 13G Filing | 0001952614-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-08-05 | 2026-07-16 | 4 | 0001493152-26-036231 | View SEC Doc Filr Page |
| 4 | 2026-07-17 | 2026-07-07 | 4 | 0001493152-26-033634 | View SEC Doc Filr Page |
| EFFECT | 2026-07-13 | — | EFFECT Filing | 9999999995-26-002279 | View SEC Doc Filr Page |
| S-3/A | 2026-07-10 | — | S-3/A | 0001493152-26-032841 | View SEC Doc Filr Page |
| S-3/A | 2026-07-08 | — | S-3/A | 0001493152-26-032503 | View SEC Doc Filr Page |
| EFFECT | 2026-07-07 | — | EFFECT Filing | 9999999995-26-002205 | View SEC Doc Filr Page |
| 8-K | 2026-07-02 | 2026-06-30 | 8-K | 0001493152-26-031972 | View SEC Doc Filr Page |
| S-3 | 2026-07-02 | — | S-3 | 0001493152-26-031967 | View SEC Doc Filr Page |
| 8-K | 2026-06-26 | 2026-06-23 | 8-K | 0001493152-26-030341 | View SEC Doc Filr Page |